CellX Biosolutions is thrilled to announce a major funding milestone with a raise of $1,700,000 designed to accelerate our groundbreaking mission to redefine chemical pollutant treatment. Born out of ETH Zurich’s innovative spirit, our startup is set on transforming how industries manage and neutralize hazardous wastes. Our pioneering approach replaces traditional, costly, and unsustainable methods like incineration with a nature-inspired solution that harnesses the power of bacteria—Nature’s master recyclers. With our patented microtechnology, we are uniquely positioned to deploy sustainable solutions directly in remote environments, where we capture and cultivate bacterial consortia capable of degrading stubborn micropollutants, including microplastics, PFAS, pesticides, and pharmaceuticals.
This new wave of funding will empower us to scale our operations and further develop our state-of-the-art technology, enabling the production of powerful cultures of degraders. By integrating these biological solutions into chemical storage reservoirs and wastewater treatment plants, we not only offer an eco-friendly alternative to harmful disposal practices but also create a significant impact in reducing the environmental footprint of industrial processes. Our investment will also drive further research and development, paving the way for broader applications of our technology in diverse sectors and reinforcing our commitment to sustainable practices.
At CellX Biosolutions, we are deeply committed to revolutionizing current pollutant management strategies. This funding brings us one step closer to a future where industries can operate efficiently while safeguarding our planet’s health. We are excited about the journey ahead as we continue to challenge the status quo and demonstrate that nature-powered solutions can indeed lead the charge against chemical pollution.
